BIORESTORATIVE THERAPIES INC (BRTX) Stock Balance Sheet
NASDAQ:BRTX - Nasdaq - US0906556065 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 547.90K | 884.40K | 1.68M | 21.03M | 3.06M | |||
| Marketable Securities | 10.18M | 10.18M | 13.07M | N/A | N/A | |||
| Receivables | 188.40K | 19.30K | 20.00K | 10.00K | 20.00K | |||
| Other Current Assets | 223.20K | 305.20K | 360.00K | 440.00K | 110.00K | |||
| Total Current Assets | 11.14M | 11.39M | 15.13M | 21.47M | 3.19M | |||
| Non-Current Assets | ||||||||
| PPE Net | 362.90K | 507.50K | 500.00K | 400.00K | 500.00K | |||
| Intangibles | 624.00K | 713.70K | 800.00K | 590.00K | 660.00K | |||
| Other Non-Current Assets | 148.70K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.14M | 1.22M | 1.30M | 980.00K | 1.16M | |||
| TOTAL ASSETS | 12.28M | 12.61M | 16.43M | 22.45M | 4.35M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 60.00K | 0.00 | |||
| Accrued Expenses | 744.50K | 874.00K | 270.00K | 250.00K | 930.00K | |||
| Accounts Payable | 483.10K | 189.40K | 170.00K | 50.00K | 120.00K | |||
| Other Current Liabilities | 2.52M | 1.54M | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 3.75M | 2.61M | 440.00K | 360.00K | 1.04M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 190.00K | 4.27M | |||
| Other Non-Current Liabilities | N/A | 0.00 | 160.00K | 300.00K | 360.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 160.00K | 500.00K | 4.64M | |||
| TOTAL LIABILITIES | 3.75M | 2.61M | 600.00K | 860.00K | 5.68M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -155.68M | -146.70M | -152.64M | -134.15M | -89.84M | |||
| Additional Paid In Capital | 164.20M | 156.69M | 168.46M | 155.73M | 88.23M | |||
| Common Shares | 14.70K | 14.50K | 20.00K | 20.00K | 290.00K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 6.92M | 4.71M | 3.68M | 3.52M | 720.00K | |||
| Tangible Book Value per Share | 1.14 | 1.97 | 4.08 | 5.96 | -2.76 | |||
| Total Shareholders' Equity | 8.53M | 10.00M | 15.83M | 21.60M | -1.33M | |||
| TOTAL LIABILITIES AND EQUITY | 12.28M | 12.61M | 16.43M | 22.45M | 4.35M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | -3.21 | |||
| Current Ratio | 2.97 | 4.37 | 34.39 | 59.64 | 3.07 | |||
| Return On Assets (ROA) | -73.12% | -82.60% | -112.54% | -197.33% | -259.08% | |||
| Return On Equity (ROE) | -105.25% | -104.13% | -116.80% | -205.09% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21